uclagrades.com

PSYCTRY 178: Cannabis and Cannabinoids: From Pharmacology to Public Policy

Relevant for those considering career in medical, social science, or policy fields. Offers comprehensive didactic information concerning Cannabis plant and relates basic information with clinical and societal use of plant and its extracts. Analysis of pharmacology of exogenous and endogenous cannabinoids at the molecular, cellular, and behavioral levels. Study of physiological and psychological actions of phytocannabinoids (focusing on THC and CBD) and synthetic cannabinoids and evidence-based research of potential benefits and harms of different cannabinoids. Review of issues related to cannabinoid policy including legislation, FDA regulation, and health care services.

4 units, lecture

Loading...

CHRISTOPHER J EVANSWinter 20266075.0% (45)
ZIVA D COOPERWinter 20266075.0% (45)

A-range % and grade counts cover only each instructor’s latest recorded term, shown in the "Latest Data From" column, combining all sections for the course. A-range % is the share of recorded letter grades (A+ through F) that are A+, A, or A−. Parentheses show the A-range count over the total letter-grade count. P/NP and incompletes are excluded. Records may be incomplete.

Available Academic Terms
Fall 2021 · Fall 2022 · Fall 2023 · Winter 2025 · Winter 2026

This website is not affiliated with UCLA. Grade distribution data from 2021–2022 was sourced through a February 2023 public records request made under the California Public Records Act. 40+ UCLA students paid $131.25 to obtain these records. Grade distribution data from 2022–2023 and 2024–2025 were sourced similarly.

UCLA students can download the data on Google Drive (log into your UCLA Google Account to access): Fall 2021–Summer 2022, Fall 2022–Spring 2023, Summer 2023–Spring 2024, Summer 2024–Spring 2025, Summer 2025–Fall 2025, Winter 2026–Spring 2026

Source code for this site is on GitHub; contributions are welcome and appreciated. Questions, comments, bug reports, and feature requests are welcome at this link.